Molecular Diagnostics

10x Genomics and Lausanne University Hospital Partner for Cancer Diagnostic Research

The collaboration will use single-cell and spatial biology platforms to identify biomarkers that predict treatment response in solid tumors.

Molecular Diagnostics

Countable Labs Launches Program Connecting Researchers With Single-Molecule PCR Services

The program connects researchers with certified laboratories offering single-molecule PCR testing, technical support, and bioinformatics expertise.

Molecular Diagnostics

FDA-Cleared Molecular Test Targets Growing US Cyclospora Outbreak

QIAGEN’s FDA-cleared QIAstat-Dx panel detects Cyclospora cayetanensis, addressing a surge of over 1,600 confirmed US cases since May 2026.

HerAnova Presents Validation Data for Endometriosis Blood Test

Jun 30, 2026 | Company News, Immunoassay, Molecular Diagnostics

HerAnova Lifesciences presented validation data for HerResolve, a blood-based endometriosis test, showing 94.4% accuracy and detection of cases missed by imaging.

Roche Launches New DNA Sequencing Platform AXELIOS 1

Jun 29, 2026 | Sequencing Systems

Roche has launched AXELIOS 1, a single-molecule sequencing platform that uses sequencing by expansion technology to deliver same-day whole-genome results.

Countable Labs and Promega Partner for Sample Preparation and Rare Variant Detection

Jun 26, 2026 | Amplification Technologies, Company News

The agreement combines extraction and PCR technologies to create an end-to-end workflow for DNA and RNA analysis.

Watchmaker Genomics Launches Tools to Streamline Sequencing Workflows

Jun 25, 2026 | Amplification Technologies, Library Preparation Systems Flow, Molecular Diagnostics

The new technologies address library normalization and amplification accuracy for high-throughput and oncology sequencing.

Myriad Genetics Expands Minimal Residual Disease Testing for Three Cancer Types

Jun 23, 2026 | Cancer, Molecular Diagnostics

The whole-genome sequencing assay is now available for breast, colorectal, and renal cancers following new clinical study results.

New Clinical Guidelines Recommend Molecular Testing for Bladder Cancer

Jun 23, 2026 | Cancer, Molecular Diagnostics

The NCCN has updated its bladder cancer guidelines to include FDA-approved ctDNA-based MRD testing for post-surgical risk assessment and adjuvant immunotherapy decisions in muscle-invasive bladder cancer.

FDA Clears Rapid Molecular Test for Group A Strep

Jun 22, 2026 | Infectious Diseases, Molecular Diagnostic Analyzers

The point-of-care assay provides results in 15 minutes and received a waiver for use in decentralized settings.

AI Reasoning Model Helps Identify Leads for Rare Disease Diagnoses

Jun 19, 2026 | Analytical Software Systems, Molecular Diagnostics

A study reports that an OpenAI reasoning model improved rare disease diagnostic yield by 4.8% in previously unsolved cases, offering new leads after specialist analysis.

Study to Evaluate One-Hour Testing for Drug-Resistant Infections

Jun 18, 2026 | Infectious Diseases, Microbiology, Molecular Diagnostics

The Fleming Initiative and Cepheid have launched a 30-month study in England to compare rapid molecular and traditional culture screening for drug-resistant carbapenemase-producing Enterobacterales in hospital settings.

Long-Read Sequencing Improves Diagnosis of Rare Genetic Disorders

Jun 18, 2026 | Molecular Diagnostic Analyzers, Molecular Diagnostics

A study reports that long-read genome sequencing can replace up to 15 separate tests and improve diagnostic yield for rare genetic disorders, according to researchers in the Netherlands.

New Guidelines Support CSF Testing for Central Nervous System Cancers

Jun 18, 2026 | Cancer, Molecular Diagnostics

The NCCN has updated its guidelines to recommend cerebrospinal fluid-based molecular profiling for inoperable high-grade gliomas and glioblastomas, expanding indications for liquid biopsy in CNS cancer care.